Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.132
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Fasted Clinical Chemistry / Glycerol
|
HET
|
10f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.387
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HET
|
10f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.496
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Simplified IPGTT / Blood glucose concentration
|
HET
|
50f:55m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Fasted Clinical Chemistry / Free fatty acids
|
HET
|
10f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.648
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Fasted Clinical Chemistry / Total cholesterol
|
HET
|
10f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.443
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Fasted Clinical Chemistry / Glucose
|
HET
|
10f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0335
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Creatinine
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000509
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
1f:m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
1f:m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
7f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.535
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.577
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
1f:m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
1f:1m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0806
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
1f:m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
1f:1m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0187
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
1f:m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
1f:1m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.948
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
1f:m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
1f:1m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.373
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total cholesterol
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
1.62×10-06
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total protein
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.384
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Cholesterol ratio
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0420
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0254
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Albumin
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.234
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.200
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0524
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total bilirubin
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0268
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.115
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
DEXA / Fat/Body weight
|
HET
|
7f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00376
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
DEXA / Fat mass
|
HET
|
7f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
6.54×10-05
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
170f:153m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
1f:1m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
1f:m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0347
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Calorimetry / Carbon dioxide production
|
HET
|
1014f:1033m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HET
|
1f:1m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HET
|
1f:m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HET
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.764
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Calorimetry / Oxygen consumption
|
HET
|
1014f:1033m
|
|
|
NotProcessed |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Calcium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00674
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Glucose
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.176
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Challenge Whole Body Plethysmography / Enhanced pause (Penh)
|
HET
|
497f:484m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Dysmorphology / fat distribution
|
HET
|
10f:9m
|
|
|
NotProcessed |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.426
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
170f:132m
|
|
|
NotProcessed |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.126
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Phosphorus
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.861
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
1f:1m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
1f:m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.694
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
1f:1m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
1f:m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0594
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
4.46×10-05
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
1f:1m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
1f:m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.705
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
1f:1m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
1f:m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.850
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
35f:35m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
1f:1m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
1f:m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.963
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
1f:1m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
1f:m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.861
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
1f:m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
1f:1m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.174
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
1f:m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
1f:1m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.153
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
1f:m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
1f:1m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.185
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
1f:m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
1f:1m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.580
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HET
|
6f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.823
|
Successful |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
2f:2m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
1f:1m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
1f:m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000822
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
170f:132m
|
|
|
NotProcessed |
Ankrd11Yod
|
MRC Harwell
|
Simplified IPGTT / Glucose response AUC
|
HET
|
10f:11m
|
Linear Mixed Model framework, LME, including Weight
|
0.723
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Gross Morphology Embryo E9.5 / Edema
|
HOM
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Triglycerides
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00654
|
Successful |
Ankrd11tm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.433
|
Successful |